{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:23:13Z","timestamp":1793496193000,"version":"4.5.0"},"reference-count":78,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Abnormal bleeding in patients with liver disease may result from elevated portal pressure and varix formation, reduced hepatic synthesis of coagulation proteins, qualitative platelet dysfunction, and\/or thrombocytopenia. Major mechanisms of thrombocytopenia in liver disease include splenic sequestration and impaired platelet production due to reduced thrombopoietin production. Alcohol and certain viruses may induce marrow suppression. Immune thrombocytopenia (ITP) may co-occur in patients with liver disease, particularly those with autoimmune liver disease or chronic hepatitis C. Drugs used for the treatment of liver disease or its complications, such as interferon, immunosuppressants, and antibiotics, may cause thrombocytopenia. Periprocedural management of thrombocytopenia of liver disease depends on both individual patient characteristics and the bleeding risk of the procedure. Patients with a platelet count higher than or equal to 50 000\/\u00b5L and those requiring low-risk procedures rarely require platelet-directed therapy. For those with a platelet count below 50 000\/\u00b5L who require a high-risk procedure, platelet-directed therapy should be considered, especially if the patient has other risk factors for bleeding, such as abnormal bleeding with past hemostatic challenges. We often target a platelet count higher than or equal to 50 000\/\u00b5L in such patients. If the procedure is elective, we prefer treatment with a thrombopoietin receptor agonist; if it is urgent, we use platelet transfusion. In high-risk patients who have an inadequate response to or are otherwise unable to receive these therapies, other strategies may be considered, such as a trial of empiric ITP therapy, spleen-directed therapy, or transjugular intrahepatic portosystemic shunt placement.<\/jats:p>","DOI":"10.1182\/hematology.2022000408","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T11:10:02Z","timestamp":1670584202000},"page":"296-302","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":39,"title":["Thrombocytopenia and liver disease: pathophysiology and periprocedural management"],"prefix":"10.1182","volume":"2022","author":[{"given":"Hana I.","family":"Lim","sequence":"first","affiliation":[{"name":"1 Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cuker","sequence":"additional","affiliation":[{"name":"2 Department of Medicine and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"1","key":"2022120916081087500_hem2022000408C1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"2022120916081087500_hem2022000408C2","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"issue":"6","key":"2022120916081087500_hem2022000408C3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/liv.13317","article-title":"Thrombocytopenia in chronic liver disease","volume":"37","author":"Peck-Radosavljevic","year":"2017","journal-title":"Liver Int"},{"issue":"3","key":"2022120916081087500_hem2022000408C4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ajg.2017.457","article-title":"Platelet count does not predict bleeding in cirrhotic patients: results from the PRO-LIVER study","volume":"113","author":"Basili","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2022120916081087500_hem2022000408C5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/hep4.1641","article-title":"Reduced clot stability by thromboelastography as a potential indicator of procedure- related bleeding in decompensated cirrhosis","volume":"5","author":"Zanetto","year":"2021","journal-title":"Hepatol Commun"},{"issue":"3","key":"2022120916081087500_hem2022000408C6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/jth.15185","article-title":"Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease","volume":"19","author":"von Meijenfeldt","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2022120916081087500_hem2022000408C7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jhep.2013.03.040","article-title":"Coagulopathy in cirrhosis\u2014the role of the platelet in hemostasis","volume":"59","author":"Tapper","year":"2013","journal-title":"J Hepatol"},{"issue":"5","key":"2022120916081087500_hem2022000408C8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/hep.510240526","article-title":"Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions","volume":"24","author":"Ordinas","year":"1996","journal-title":"Hepatology"},{"issue":"1","key":"2022120916081087500_hem2022000408C9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"issue":"12","key":"2022120916081087500_hem2022000408C10","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1111\/jth.13863","article-title":"Soluble fibrin causes an acquired platelet glycoprotein VI signaling defect: implications for coagulopathy","volume":"15","author":"Lee","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2022120916081087500_hem2022000408C11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.1840160411","article-title":"Elevated fibrin-related and fibrinogen-related antigens in patients with liver disease","volume":"16","author":"Kruskal","year":"1992","journal-title":"Hepatology"},{"issue":"24","key":"2022120916081087500_hem2022000408C12","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJM196706152762403","article-title":"Platelet aggregation in patients with Laennec's cirrhosis of the liver","volume":"276","author":"Thomas","year":"1967","journal-title":"N Engl J Med"},{"issue":"11","key":"2022120916081087500_hem2022000408C13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2036.2008.03674.x","article-title":"Review article: blood platelet number and function in chronic liver disease and cirrhosis","volume":"27","author":"Witters","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2022120916081087500_hem2022000408C14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2022.03.009","article-title":"Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death","volume":"77","author":"Zanetto","year":"2022","journal-title":"J Hepatol"},{"issue":"8","key":"2022120916081087500_hem2022000408C15","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gutjnl-2019-319044","article-title":"Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS","volume":"69","author":"Queck","year":"2020","journal-title":"Gut"},{"issue":"6","key":"2022120916081087500_hem2022000408C16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhepr.2019.10.001","article-title":"Platelets in chronic liver disease, from bench to bedside","volume":"1","author":"Ramadori","year":"2019","journal-title":"JHEP Rep"},{"key":"2022120916081087500_hem2022000408C17","first-page":"9","article-title":"Splenic pooling and the pathophysiology of hypersplenism","volume":"78","author":"Jandl","year":"1967","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"7","key":"2022120916081087500_hem2022000408C18","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/j.1572-0241.1999.01231.x","article-title":"Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis","volume":"94","author":"Kawasaki","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2022120916081087500_hem2022000408C19","doi-asserted-by":"crossref","first-page":"e0192271","DOI":"10.1371\/journal.pone.0192271","article-title":"Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: a cohort study","volume":"13","author":"Rauber","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"2022120916081087500_hem2022000408C20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V87.2.567.bloodjournal872567","article-title":"Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets","volume":"87","author":"Stoffel","year":"1996","journal-title":"Blood"},{"issue":"9","key":"2022120916081087500_hem2022000408C21","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.3390\/ijms21093294","article-title":"Primary hemostasis in chronic liver disease and cirrhosis: what did we learn over the past decade?","volume":"21","author":"van Dievoet","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2022120916081087500_hem2022000408C22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1386-6346(01)00170-X","article-title":"Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression","volume":"23","author":"Ishikawa","year":"2002","journal-title":"Hepatol Res"},{"issue":"6","key":"2022120916081087500_hem2022000408C23","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1572-0241.2005.41543.x","article-title":"The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis","volume":"100","author":"Rios","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"2022120916081087500_hem2022000408C24","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1055\/s-0037-1615024","article-title":"Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations","volume":"79","author":"Koike","year":"1998","journal-title":"Thromb Haemost"},{"issue":"5","key":"2022120916081087500_hem2022000408C25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-0035-1550432","article-title":"Platelet dysfunction: status of thrombopoietin in thrombocytopenia associated with chronic liver failure","volume":"41","author":"Giannini","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"2022120916081087500_hem2022000408C26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-127-4-199708150-00005","article-title":"Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation","volume":"127","author":"Martin TG","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"2022120916081087500_hem2022000408C27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V95.3.795.003k25_795_801","article-title":"Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production","volume":"95","author":"Peck-Radosavljevic","year":"2000","journal-title":"Blood"},{"issue":"April","key":"2022120916081087500_hem2022000408C28","first-page":"39","article-title":"The pathophysiology of thrombocytopenia in chronic liver disease","volume":"8","author":"Mitchell","year":"2016","journal-title":"Hepat Med"},{"issue":"2","key":"2022120916081087500_hem2022000408C29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI112591","article-title":"In vitro hepatitis B virus infection of human bone marrow cells","volume":"78","author":"Zeldis","year":"1986","journal-title":"J Clin Invest"},{"issue":"2","key":"2022120916081087500_hem2022000408C30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ajh.21600","article-title":"Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility","volume":"85","author":"Klco","year":"2010","journal-title":"Am J Hematol"},{"issue":"7","key":"2022120916081087500_hem2022000408C31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM196908142810701","article-title":"Hematologic effects of alcohol in man in the absence of nutritional deficiency","volume":"281","author":"Lindenbaum","year":"1969","journal-title":"N Engl J Med"},{"issue":"1","key":"2022120916081087500_hem2022000408C32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0038-1661125","article-title":"The effects of administration of ethyl alcohol to mice on megakaryocyte and platelet development","volume":"52","author":"Cooper","year":"1984","journal-title":"Thromb Haemost"},{"issue":"3","key":"2022120916081087500_hem2022000408C33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/jcp.36.3.337","article-title":"Changes in the blood platelets of alcoholics during alcohol withdrawal","volume":"36","author":"Fink","year":"1983","journal-title":"J Clin Pathol"},{"issue":"6","key":"2022120916081087500_hem2022000408C34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopenia associated with chronic liver disease","volume":"48","author":"Afdhal","year":"2008","journal-title":"J Hepatol"},{"issue":"3","key":"2022120916081087500_hem2022000408C35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2007-12-125906","article-title":"Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes","volume":"112","author":"Yamane","year":"2008","journal-title":"Blood"},{"issue":"5","key":"2022120916081087500_hem2022000408C36","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/hep.510280535","article-title":"Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C","volume":"28","author":"Peck-Radosavljevic","year":"1998","journal-title":"Hepatology"},{"issue":"8","key":"2022120916081087500_hem2022000408C37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/gut.34.8.1081","article-title":"Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience","volume":"34","author":"Connell","year":"1993","journal-title":"Gut"},{"issue":"6","key":"2022120916081087500_hem2022000408C38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2016-03-708594","article-title":"Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota","volume":"129","author":"Josefsdottir","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2022120916081087500_hem2022000408C39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/asheducation-2018.1.576","article-title":"Drug-associated thrombocytopenia","volume":"2018","author":"Bakchoul","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"2022120916081087500_hem2022000408C40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF02389532","article-title":"Primary biliary cirrhosis associated with idiopathic thrombocytopenic purpura","volume":"31","author":"Mizukami","year":"1996","journal-title":"J Gastroenterol"},{"issue":"10","key":"2022120916081087500_hem2022000408C41","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/gut.26.10.1074","article-title":"Platelet associated immunoglobulins in primary biliary cirrhosis: a cause of thrombocytopenia?","volume":"26","author":"Bassendine","year":"1985","journal-title":"Gut"},{"issue":"December","key":"2022120916081087500_hem2022000408C42","first-page":"5305691","article-title":"Autoimmune hepatitis with concomitant idiopathic thrombocytopenic purpura diagnosed by transjugular liver biopsy","volume":"2018","author":"Fukuda","year":"2018","journal-title":"Case Reports Hepatol"},{"issue":"2","key":"2022120916081087500_hem2022000408C43","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.clinre.2012.11.001","article-title":"Autoimmune hepatitis-primary biliary cirrhosis overlap syndrome concomitant with immune hemolytic anemia and immune thrombocytopenic purpura (Evans syndrome)","volume":"37","author":"Korkmaz","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"8","key":"2022120916081087500_hem2022000408C44","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/j.1572-0241.2002.05845.x","article-title":"Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection","volume":"97","author":"Pockros","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"suppl 1","key":"2022120916081087500_hem2022000408C45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2036.2007.03512.x","article-title":"Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease","volume":"26","author":"Weksler","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2022120916081087500_hem2022000408C46","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/jgh.13252","article-title":"Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis","volume":"31","author":"van der Meer","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"2022120916081087500_hem2022000408C47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ajh.1180","article-title":"Treatment of hepatitis C related thrombocytopenia with interferon alpha","volume":"68","author":"Rajan","year":"2001","journal-title":"Am J Hematol"},{"issue":"9","key":"2022120916081087500_hem2022000408C48","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cgh.2009.04.019","article-title":"A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation","volume":"7","author":"Vieira da Rocha","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2022120916081087500_hem2022000408C49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF01313579","article-title":"Bleeding after liver biopsy does not correlate with indices of peripheral coagulation","volume":"26","author":"Ewe","year":"1981","journal-title":"Dig Dis Sci"},{"issue":"3","key":"2022120916081087500_hem2022000408C50","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"2022120916081087500_hem2022000408C51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cld.2020.04.009","article-title":"Thrombocytopenia in chronic liver disease: new management strategies","volume":"24","author":"Nilles","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"8","key":"2022120916081087500_hem2022000408C52","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jvir.2019.04.017","article-title":"Society of interventional radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions. II: recommendations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe","volume":"30","author":"Patel","year":"2019","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"2022120916081087500_hem2022000408C53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG clinical guideline: disorders of the hepatic and mesenteric circulation","volume":"115","author":"Simonetto","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2022120916081087500_hem2022000408C54","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1053\/j.gastro.2021.08.015","article-title":"AGA clinical practice guideline on the management of coagulation disorders in patients with cirrhosis","volume":"161","author":"O'Shea","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"2022120916081087500_hem2022000408C55","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"2022120916081087500_hem2022000408C56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jth.15562","article-title":"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH","volume":"20","author":"Roberts","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2022120916081087500_hem2022000408C57","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","author":"European Association for the Study of the Liver","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"2022120916081087500_hem2022000408C58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ejh.13342","article-title":"Transfusion strategies in patients with cirrhosis","volume":"104","author":"Liu","year":"2020","journal-title":"Eur J Haematol"},{"issue":"2","key":"2022120916081087500_hem2022000408C59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"2022120916081087500_hem2022000408C60","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1055\/s-0040-1715451","article-title":"Thrombopoietin receptor agonists in patients with chronic liver disease","volume":"46","author":"Khemichian","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2022120916081087500_hem2022000408C61","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","article-title":"Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia","volume":"155","author":"Terrault","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"2022120916081087500_hem2022000408C62","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cgh.2018.11.047","article-title":"Lusutrombopag reduces need for platelet transfusion in patients with thrombocytopenia undergoing invasive procedures","volume":"17","author":"Hidaka","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2022120916081087500_hem2022000408C63","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.30561","article-title":"Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2)","volume":"70","author":"Peck-Radosavljevic","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"2022120916081087500_hem2022000408C64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2011.01.020","article-title":"Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura","volume":"55","author":"Dultz","year":"2011","journal-title":"J Hepatol"},{"issue":"8","key":"2022120916081087500_hem2022000408C65","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1110709","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia","volume":"367","author":"Afdhal","year":"2012","journal-title":"N Engl J Med"},{"key":"2022120916081087500_hem2022000408C66","unstructured":"Miller JB , FigueroaEJ, HaugRM, ShahNL. Thrombocytopenia in chronic liver disease and the role of thrombopoietin agonists. Gastroenterol Hepatol (NY). 2019;15(6):326-332. https:\/\/pubmed.ncbi.nlm.nih.gov\/31391802\/. Accessed 4September2022."},{"issue":"5","key":"2022120916081087500_hem2022000408C67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4329\/wjr.v6.i5.160","article-title":"Partial splenic artery embolization in cirrhotic patients","volume":"6","author":"Hadduck","year":"2014","journal-title":"World J Radiol"},{"issue":"10","key":"2022120916081087500_hem2022000408C68","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1155\/2014\/532191","article-title":"Management of thrombocytopenia in advanced liver disease","volume":"28","author":"Gangireddy","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"3","key":"2022120916081087500_hem2022000408C69","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2168.2000.01383-16.x","article-title":"Portal vein thrombosis following splenectomy","volume":"87","author":"Hassn","year":"2000","journal-title":"Br J Surg"},{"issue":"4","key":"2022120916081087500_hem2022000408C70","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jvir.2006.12.734","article-title":"Partial splenic embolization in the treatment of patients with portal hypertension: a review of the English language literature","volume":"18","author":"Koconis","year":"2007","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"2022120916081087500_hem2022000408C71","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF01655282","article-title":"Partial splenic embolization: experience in 136 patients","volume":"9","author":"Jonasson","year":"1985","journal-title":"World J Surg"},{"issue":"8","key":"2022120916081087500_hem2022000408C72","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s00268-009-0095-2","article-title":"Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients","volume":"33","author":"Amin","year":"2009","journal-title":"World J Surg"},{"issue":"9","key":"2022120916081087500_hem2022000408C73","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJMoa030254","article-title":"Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone","volume":"349","author":"Cheng","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"2022120916081087500_hem2022000408C74","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.V62.2.480.480","article-title":"Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura","volume":"62","author":"Bussel","year":"1983","journal-title":"Blood"},{"issue":"6","key":"2022120916081087500_hem2022000408C75","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/cld.736","article-title":"Steroids for severe alcoholic hepatitis: more risk than reward?","volume":"12","author":"Dao","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"8","key":"2022120916081087500_hem2022000408C76","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2021.07.018","article-title":"North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension","volume":"20","author":"Boike","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2022120916081087500_hem2022000408C77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.dld.2016.10.011","article-title":"Italian Association of the Study of the Liver Transjugular Intrahepatic Portosystemic Shunt Special Conference. Consensus conference on TIPS management: techniques, indications, contraindications","volume":"49","author":"Fagiuoli","year":"2017","journal-title":"Dig Liver Dis"},{"key":"2022120916081087500_hem2022000408C78","unstructured":"Massoud OI , ZeinNN. The effect of transjugular intrahepatic portosystemic shunt on platelet counts in patients with liver cirrhosis. Gastroenterol Hepatol (NY). 2017;13(5):286-291. https:\/\/www.gastroenterologyandhepatology.net\/files\/2017\/05\/gh0517Massoud-Zein-1.pdf. Accessed 5September2022."}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/296\/2021803\/296lim.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/296\/2021803\/296lim.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:26:13Z","timestamp":1728519973000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2022\/1\/296\/493505\/Thrombocytopenia-and-liver-disease-pathophysiology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,9]]},"published-print":{"date-parts":[[2022,12,9]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2022000408","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,9]]},"published":{"date-parts":[[2022,12,9]]}}}